Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 Feb;19(2):260–265. doi: 10.1128/aac.19.2.260

Ribosomal binding region for the antibiotic tiamulin: stoichiometry, subunit location, and affinity for various analogs.

G Högenauer, C Ruf
PMCID: PMC181405  PMID: 6751216

Abstract

Equilibrium dialysis experiments with a highly purified preparation of labeled tiamulin, a semisynthetic derivative of the antibiotic pleuromutilin, and Escherichia coli ribosomes allowed the determination of two binding sites for the drug. The binding reaction showed a cooperative effect. Of the two subunits, the 50S particle was able to bind the antibiotic in a 1:1 stoichiometry. Hence, the 50S subunit contributed predominantly to the binding energy which held the antibiotic to the ribosomes. The 30S subunit, showing no strong affinity for the drug, may be needed for the generation of the second binding site in the 70S particle. If depleted of ammonium ions, 70S ribosomes lost their binding capacity for the antibiotic. The attachment sites for tiamulin could be restored by heating the ribosomes to 40 degrees C in the presence of either ammonium ions or the antibiotic. Other pleuromutilin derivatives displaced labeled tiamulin from its ribosomal binding sites. By quantifying this competition, the relative affinity of various pleuromutilin derivatives for E. coli ribosomes was determined. The binding correlated with the minimal inhibitory concentrations of these compounds against E. coli. When compared with the minimal inhibitory concentrations of these compounds against E. coli. When compared with the minimal inhibitory concentrations against E. coli. When compared with the minimal inhibitory concentrations against Staphylococcus aureus, the correlation was less strict, but the same trend prevailed. These results suggest that the antibacterial activities of various pleuromutilin derivatives on a given test organism are mainly determined by the strength of binding to the ribosomes within the bacterial cell.

Full text

PDF
260

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dornhelm P., Högenauer G. The effects of tiamulin, a semisynthetic pleuromutilin derivative, on bacterial polypeptide chain initiation. Eur J Biochem. 1978 Nov 15;91(2):465–473. doi: 10.1111/j.1432-1033.1978.tb12699.x. [DOI] [PubMed] [Google Scholar]
  2. Egger H., Reinshagen H. New pleuromutilin derivatives with enhanced antimicrobial activity. I. Synthesis. J Antibiot (Tokyo) 1976 Sep;29(9):915–922. doi: 10.7164/antibiotics.29.915. [DOI] [PubMed] [Google Scholar]
  3. Egger H., Reinshagen H. New pleuromutilin derivatives with enhanced antimicrobial activity.II.Structure-activity correlations. J Antibiot (Tokyo) 1976 Sep;29(9):923–927. doi: 10.7164/antibiotics.29.923. [DOI] [PubMed] [Google Scholar]
  4. Hodgin L. A., Högenauer G. The mode of action of pleuromutilin derivatives. Effect on cell-free polypeptide synthesis. Eur J Biochem. 1974 Sep 16;47(3):527–533. doi: 10.1111/j.1432-1033.1974.tb03721.x. [DOI] [PubMed] [Google Scholar]
  5. Högenauer G. The mode of action of pleuromutilin derivatives. Location and properties of the pleuromutilin binding site on Escherichia coli ribosomes. Eur J Biochem. 1975 Mar 3;52(1):93–98. doi: 10.1111/j.1432-1033.1975.tb03976.x. [DOI] [PubMed] [Google Scholar]
  6. Högenauer G. The stability of a codon transfer RNA complex. Eur J Biochem. 1970 Feb;12(3):527–532. doi: 10.1111/j.1432-1033.1970.tb00882.x. [DOI] [PubMed] [Google Scholar]
  7. Mao J. C., Putterman M. The intermolecular complex of erythromycin and ribosome. J Mol Biol. 1969 Sep 14;44(2):347–361. doi: 10.1016/0022-2836(69)90180-6. [DOI] [PubMed] [Google Scholar]
  8. Miskin R., Zamir A., Elson D. Inactivation and reactivation of ribosomal subunits: the peptidyl transferase activity of the 50 s subunit of Escherihia coli. J Mol Biol. 1970 Dec 14;54(2):355–378. doi: 10.1016/0022-2836(70)90435-3. [DOI] [PubMed] [Google Scholar]
  9. NIRENBERG M. W., MATTHAEI J. H. The dependence of cell-free protein synthesis in E. coli upon naturally occurring or synthetic polyribonucleotides. Proc Natl Acad Sci U S A. 1961 Oct 15;47:1588–1602. doi: 10.1073/pnas.47.10.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Oleinick N. L., Corcoran J. W. Two types of binding of erythromycin to ribosomes from antibiotic-sensitive and -resistant Bacillus subtilis 168. J Biol Chem. 1969 Feb 25;244(4):727–735. [PubMed] [Google Scholar]
  11. Teraoka H. A reversible change in the ability of Escherichia coli ribosomes to bind to erythromycin. J Mol Biol. 1970 Mar;48(3):511–515. doi: 10.1016/0022-2836(70)90062-8. [DOI] [PubMed] [Google Scholar]
  12. Vogel Z., Vogel T., Elson D., Zamir A. Ribosome activation and the binding of dihydrostreptomycin: effect of polynucleotides and temperature on activation. J Mol Biol. 1970 Dec 14;54(2):379–386. doi: 10.1016/0022-2836(70)90436-5. [DOI] [PubMed] [Google Scholar]
  13. Vogel Z., Vogel T., Zamir A., Elson D. Correlation between the peptidyl transferase activity of the 50 s ribosomal subunit and the ability of the subunit to interact with antibiotics. J Mol Biol. 1971 Sep 14;60(2):339–346. doi: 10.1016/0022-2836(71)90298-1. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES